| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- manufacturers
- (E/Z)-Sivopixant
-
- $88.00
-
2026-07-14
- CAS:1640808-39-4
- Purity: 99.82%
- Supply Ability: 10g
|
| | 1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- Basic information |
| Product Name: | 1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- | | Synonyms: | 1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)-;(E/Z)-Sivopixant;(E/Z)-Sivopixant, 10 mM in DMSO | | CAS: | 1640808-39-4 | | MF: | C25H22ClN5O5 | | MW: | 507.93 | | EINECS: | | | Product Categories: | | | Mol File: | 1640808-39-4.mol | ![1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- Structure](CAS/20211123/GIF/1640808-39-4.gif) |
| | 1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- Chemical Properties |
| Boiling point | 674.5±65.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (196.88 mM; Need ultrasonic) | | form | Solid | | pka | 4.55±0.10(Predicted) | | color | White to off-white |
| | 1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- Usage And Synthesis |
| Uses | (E/Z)-Sivopixant ((E/Z)-S-600918) is a potent P2X3 receptor antagonist with an IC50 of 4 nM. (E/Z)-Sivopixant can be used for respiratory diseases research[1]. | | References | [1] Kai, Hiroyuki, et al. Amino-triazine derivatives and pharmaceutical composition containing said derivatives. WO2014200078A1. |
| | 1,3,5-Triazine-1(2H)-propanoic acid, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-α-methyl-2,6-dioxo-4-[[4-(2-pyridinyloxy)phenyl]amino]-, (αS)- Preparation Products And Raw materials |
|